US2021355499A1PendingUtilityA1
Plant Vectors, Compositions and Uses Relating Thereto
Est. expiryMay 12, 2040(~13.8 yrs left)· nominal 20-yr term from priority
Inventors:Anne Elizabeth Simon
C12N 15/86C12N 15/8281C12N 15/8218C12N 15/64C12N 15/67C12N 15/8201C12N 2770/26043
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to a single stranded RNA vector suitable for introducing a therapeutic agent, such as a peptide, a protein or a small RNA, into a host plant. The vector does not encode for any movement protein or coat protein, but is capable of capable of systemic and phloem-limited movement and replication within the host plant.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A plus-sense single stranded ribonucleic acid (RNA) vector comprising a heterologous segment(s), wherein said heterologous element(s) is attached to the RNA vector through a lock and dock structure.
2 . The RNA vector of claim 1 , which comprises a 3′ Cap Independent Translation Enhancer (3′ CITE) comprising the nucleic acid sequence(s) of SEQ ID NO: 4 and/or SEQ ID NO: 5.
3 . The RNA vector of claim 2 , wherein said 3′ CITE comprises the nucleic acid sequence of SEQ ID NO: 3.
4 . The RNA vector of claim 1 , having a replication element(s) comprising one or more conserved polynucleotide sequence(s) having the nucleic acid sequence of: SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, and/or SEQ ID NO: 14.
5 . The RNA vector of claim 4 , wherein said replication element(s) further comprises one of more conserved polynucleotide sequence(s) having the nucleic acid sequence of: SEQ ID NO: 15 and/or SEQ ID NO: 16.
6 . The RNA vector of claim 1 , which is derived from citrus yellow vein virus (SEQ ID NO:1) or an iRNA relative thereof.
7 . The RNA vector of claim 1 , which is capable of systemic and phloem-limited movement and replication within a host plant.
8 . The RNA vector of claim 1 , wherein the lock and dock structure comprises a branched element, wherein a stem and a branch of the branched element are located within a stable structure such as a tetraloop-tetraloop dock, and another branch of the branched element comprises an insert site for the heterologous element.
9 . An iRNA-based vector having a heterologous segment(s) comprises an siRNA effective against a plant pathogenic bacteria.
10 . The iRNA-based vector of claim 9 , wherein said siRNA targets a Candidatus Liberibacter species.
11 . The iRNA-based vector of claim 10 , wherein said Candidatus Liberibacter species is Candidatus Liberibacter asiaticus (CLas).
12 . An iRNA-based vector comprising a heterologous element comprising a hairpin having a sequence on one side complementary to a sequence within Citrus tristeza virus (CTV).
13 . The iRNA-based vector of claim 12 , wherein the sequence within CTV is conserved in multiple CTV strains.
14 . A plant comprising a sour orange rootstock and an iRNA-based vector comprising a heterologous element that targets a nucleic acid of Citrus tristeza virus (CTV).
15 . The plant of claim 14 , wherein the heterologous element comprises a hairpin having a sequence on one side complementary to a sequence within Citrus tristeza virus (CTV), optionally a sequence conserved in multiple CTV strains.
16 . A method for introducing a heterologous segment(s) into a host plant comprising introducing into said host plant an iRNA-based vector after a) encapsidating the iRNA vector in a capsid protein other than the capsid protein of CVEV, or b) by agroinfiltration after inoculating an agroinfiltration site with Xanthomonas citri subsp. citri (Xcc).
17 . An iRNA-based vector comprising one or more inserts at one or more of positions 2250, 2301, 2319, 2330, 2331, 2336 and 2083 of a CYVaV based RNA.
18 . The iRNA-based vector of claim 17 comprising one or more inserts at one or more of positions 2250, 2301, 2319, 2330 and 2336 of a CYVaV based RNA.
19 . The iRNA-based vector of claim 17 , wherein the CYVaV based RNA comprises stabilizing changes.
20 . The iRNA-based vector of claim 19 , wherein the CYVaV based RNA comprises changes converting G:U pairs to G:C pairs in the 3′UTR structure.
21 . A method of making a plus-sense single stranded ribonucleic acid (RNA) vector comprising stabilizing the 3′ UTR structure of a parental construct and inserting one or more destabilizing heterologous segment(s) into the stabilized parental construct.Join the waitlist — get patent alerts
Track US2021355499A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.